Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Carmustine). Showing records 1 – 5 of 5 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Oregon State University

1. Giese, Neill Alan. The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat.

Degree: MS, Pharmacology and Toxicology, 1980, Oregon State University

Subjects/Keywords: Carmustine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Giese, N. A. (1980). The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat. (Masters Thesis). Oregon State University. Retrieved from http://hdl.handle.net/1957/42315

Chicago Manual of Style (16th Edition):

Giese, Neill Alan. “The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat.” 1980. Masters Thesis, Oregon State University. Accessed January 18, 2021. http://hdl.handle.net/1957/42315.

MLA Handbook (7th Edition):

Giese, Neill Alan. “The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat.” 1980. Web. 18 Jan 2021.

Vancouver:

Giese NA. The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat. [Internet] [Masters thesis]. Oregon State University; 1980. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/1957/42315.

Council of Science Editors:

Giese NA. The effect of carmustine (BCNU) on hepatic UDP-glucuronyltransferase activity in the rat. [Masters Thesis]. Oregon State University; 1980. Available from: http://hdl.handle.net/1957/42315

2. Daminelli, Elaine Nunes. Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos.

Degree: PhD, Cardiologia, 2015, University of São Paulo

A aterosclerose é uma doença inflamatória crônica e proliferativa que tem início quando fatores de risco alteram o endotélio vascular. As partículas da nanoemulsão lipídica… (more)

Subjects/Keywords: Aterosclerose; Atherosclerosis; Carmustina; Carmustine; Coelhos; Hipercolesterolemia; Hypercholesterolemia; Inflamação; Inflammation; Nanoparticles; Nanopartículas; Rabbits

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Daminelli, E. N. (2015). Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/5/5131/tde-11052015-161325/ ;

Chicago Manual of Style (16th Edition):

Daminelli, Elaine Nunes. “Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos.” 2015. Doctoral Dissertation, University of São Paulo. Accessed January 18, 2021. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-11052015-161325/ ;.

MLA Handbook (7th Edition):

Daminelli, Elaine Nunes. “Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos.” 2015. Web. 18 Jan 2021.

Vancouver:

Daminelli EN. Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos. [Internet] [Doctoral dissertation]. University of São Paulo; 2015. [cited 2021 Jan 18]. Available from: http://www.teses.usp.br/teses/disponiveis/5/5131/tde-11052015-161325/ ;.

Council of Science Editors:

Daminelli EN. Uso de carmustina associada a nanoemulsões ricas em colesterol (LDE) para tratamento da aterosclerose induzida em coelhos. [Doctoral Dissertation]. University of São Paulo; 2015. Available from: http://www.teses.usp.br/teses/disponiveis/5/5131/tde-11052015-161325/ ;


Univerzitet u Beogradu

3. Stojković-Burić, Sonja M., 1985-. Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo.

Degree: Biološki fakultet, 2017, Univerzitet u Beogradu

Molekularna onkologija - Kancerogeneza / Molecular oncology - Cancerogenesis

Uspešnost terapije glioblastoma, najĉešćeg i najagresivnijeg malignog tumora centralnog nervnog sistema, je osujećena usled visokog stepena… (more)

Subjects/Keywords: Glioblastoma; chemoresistance; carmustine (BCNU); temozolomide (TMZ); collateral sensitivity; invasiveness; antiglioma therapy; CoQ10

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stojković-Burić, Sonja M., 1. (2017). Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:15650/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Stojković-Burić, Sonja M., 1985-. “Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo.” 2017. Thesis, Univerzitet u Beogradu. Accessed January 18, 2021. https://fedorabg.bg.ac.rs/fedora/get/o:15650/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Stojković-Burić, Sonja M., 1985-. “Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo.” 2017. Web. 18 Jan 2021.

Vancouver:

Stojković-Burić, Sonja M. 1. Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo. [Internet] [Thesis]. Univerzitet u Beogradu; 2017. [cited 2021 Jan 18]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15650/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Stojković-Burić, Sonja M. 1. Model ćelija C6 glioma pacova kao oruđe za pronalaženje novih terapeutskih strategija: karakterizacija rezistentnog fenotipa in vitro i in vivo. [Thesis]. Univerzitet u Beogradu; 2017. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15650/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

4. Gutowski, Pawel. The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter.

Degree: 2016, Freie Universität Berlin

 Glioblastoma multiforme is the most common and most aggressive primary brain tumor (WHO grade IV). Despite all the care taken to treat the tumor the… (more)

Subjects/Keywords: glioblastoma multiforme; GBM; MGMT; Gliadel; Carmustine Wafer; Pyrosequencing; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gutowski, P. (2016). The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-5535

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gutowski, Pawel. “The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter.” 2016. Thesis, Freie Universität Berlin. Accessed January 18, 2021. http://dx.doi.org/10.17169/refubium-5535.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gutowski, Pawel. “The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter.” 2016. Web. 18 Jan 2021.

Vancouver:

Gutowski P. The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter. [Internet] [Thesis]. Freie Universität Berlin; 2016. [cited 2021 Jan 18]. Available from: http://dx.doi.org/10.17169/refubium-5535.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gutowski P. The survival benefit for glioblastoma patients treated with carmustine wafer in relation to the methylation of O6-Methylguanine-DNA-Methyltransferase promoter. [Thesis]. Freie Universität Berlin; 2016. Available from: http://dx.doi.org/10.17169/refubium-5535

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

5. Mihaliak, Alicia M. Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation.

Degree: Interdisciplinary Graduate Program, Biochemistry and Molecular Pharmacology, 2010, U of Massachusetts : Med

  My thesis research began with a project in which we were trying to determine the function of embryonic stem cell (ESC)-specific miRNAs. Using luciferase… (more)

Subjects/Keywords: Glioblastoma; Drug Therapy; Cell Proliferation; Carmustine; Dacarbazine; Cancer Biology; Cells; Embryonic Structures; Genetic Phenomena; Heterocyclic Compounds; Neoplasms; Organic Chemicals; Pharmaceutical Preparations; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mihaliak, A. M. (2010). Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation. (Doctoral Dissertation). U of Massachusetts : Med. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/492

Chicago Manual of Style (16th Edition):

Mihaliak, Alicia M. “Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation.” 2010. Doctoral Dissertation, U of Massachusetts : Med. Accessed January 18, 2021. https://escholarship.umassmed.edu/gsbs_diss/492.

MLA Handbook (7th Edition):

Mihaliak, Alicia M. “Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation.” 2010. Web. 18 Jan 2021.

Vancouver:

Mihaliak AM. Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation. [Internet] [Doctoral dissertation]. U of Massachusetts : Med; 2010. [cited 2021 Jan 18]. Available from: https://escholarship.umassmed.edu/gsbs_diss/492.

Council of Science Editors:

Mihaliak AM. Clinically Relevant Doses of Chemotherapy Drugs Selectively and Reversibly Block Glioblastoma Neurosphere Proliferation in vitro: A Dissertation. [Doctoral Dissertation]. U of Massachusetts : Med; 2010. Available from: https://escholarship.umassmed.edu/gsbs_diss/492

.